Site Search

The ULTRA-DD project has made good on its promise to make its data open source with the publication online of datasets from experiments on autoimmune diseases such as lupus and myositis. Through the experiments, the ULTRA-DD team has identified potential new targets that could ...

The incidence of cancer in Europe is increasing but many potential new drug treatments are found to be ineffective when tested on patients. IMI's PREDECT project has investigated new models of tumours to help researchers discover more effective treatments and boost survival rates ...

New treatments must be tested in clinical trials to ensure they are safe and effective. IMI's EHR4CR project has enabled scientists to find suitable patients by searching millions of medical records while keeping personal data secure.

IMI projects are accelerating the medicines development process, generating new scientific insights, and developing resources for open use by the research community. Furthermore, some of our projects are already delivering direct benefits to patients. Interested in concrete ...

IMI's QuIC-ConCePT project research into validating more imaging biomarkers for use in cancer drug trials seeks to speed up development of successful new drugs and avoid exposing patients to treatment that does not work for them.